Constitución del Comité Científico de FAST España
El pasado 28/04/2021 se celebró la reunión de constitución del Comité Científico de FAST España. El Comité está formado por las Unidades Monográfica
FAST asigna fondos para el Consorcio de Atención de Emergencia de Epilepsia para pacientes con Síndrome de Angelman a través de una línea telefónica directa (Emergency Care Consortium for Seizure Hotline)
FAST establece el Consorcio de Atención de Emergencia para ayudar a más del 90% de individuos con el Síndrome de Angelman que han reportado tener epilepsi
Interview with FAST UK Chairperson Tom Keogh
How was FAST UK born? “FAST (Foundation for Angelman Syndrome Therapeutics) UK was born after our eldest daughter Amelia was diagnosed with Angelman syndro
August Newsletter
AS & Artificial Intelligence in the News, FAST and Lixte Collaborate to support preclinical study Dr. Jiang seeking participants, Upcoming concert by Joe
First FAST Gala
December 6th 2008 not only marked the official launch of the new foundation, Foundation for Angelman Syndrome Therapeutics(“FAST”), but also became a nig
Bienvenue FAST France
FAST is proud to announce the newest addition to its global family: FAST France. Charlotte Prestat and Anthony Moisan, the founders of FAST France, have thre
Global Angelman Syndrome Registry moves platform to QUT
The Global Angelman Syndrome Registry (Registry) had some downtime this week while the platform was moved to the Division of Researc
Frequently asked questions regarding the GeneTx KIK-AS Clinical Trial
GeneTx Biotherapeutics has announced it has received IRB approval from Rush University Medical Center in Chicago, IL to begin the «KIK-AS» (Knockdown of UB
A message to the Angelman community from GeneTx Biotherapeutics
Two press releases were issued recently with one announcing an Exclusive Option Agreement between GeneTx Biotherapeutics, LLC («GeneTx») and Ultragenyx
GeneTx Biotherapeutics receives FDA orphan-drug designation for Angelman syndrome treatment
Downers Grove, Ill., March 27, 2018 – The U.S. Food and Drug Administration has granted orphan-drug designation to GeneTx Biotherapeutics LLC’s GTX-101 f